Adapted HOPE-C for Gynecologic Oncology Clinician Burnout
This study is testing an adapted program called Helping Ovarian Cancer Patients Cope-Clinician Burnout (HOPE-C). This program aims to help gynecologic oncology clinicians (doctors, nurses, social workers, and advanced practice providers who work with ovarian cancer patients) deal with stress and burnout. The original HOPE program helps ovarian cancer patients find hope. This study wants to see if the adapted HOPE-C program is helpful for clinicians. Researchers will look at feedback from clinicians and how many complete the program. You can join if you are 18 or older, speak English, and work with ovarian cancer patients. The study status is currently unclear.
- Study design
- This interventional study plans to enroll 25 participants. It is testing a behavioral intervention called HOPE-C.
- What's involved
- You would review intervention materials, complete an interview and questionnaire, and attend weekly HOPE-C sessions for 4 weeks, each lasting 30-45 minutes.
- Compensation
- Not stated in the trial record.
- Follow-up
- Feasibility of intervention completion is measured at 4 weeks after enrollment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Megan J. Shen, PhD · PRINCIPAL_INVESTIGATOR · Fred Hutch/University of Washington Cancer Consortium
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Objective 1: Clinician feedback for Helping Ovarian Cancer Patients Cope-Clinician Burnout (HOPE-C)Day 1
Will assess clinician's feedback around the content, delivery structure, and materials for the adapted HOPE-C intervention. Qualitative Description will be used to analyze the data.
- Objective 2: Feasibility (Accrual rate)At time of enrollment
Feasibility cutoff includes ≥ 50% of eligible clinicians enrolling in the study.
- Objective 2: Feasibility (Rate of intervention completion)At 4 weeks
Feasibility cutoff includes ≥ 50% of enrolled clinicians completing all sessions.
- Objective 2: Feasibility (Rate of survey completion)At baseline and 2-week post-intervention
Feasibility cutoff includes ≥ 50% of enrolled clinicians completing all surveys.
- Objective 2: Acceptability of HOPE-CAt 2-week post-intervention
Assessed by the Theoretical Framework of Acceptability (TFA) questionnaire, which is an 8-item questionnaire assessing acceptability of healthcare interventions across seven constructions: Affective Attitude, Burden, Ethicality, Intervention Coherence, Opportunity Costs, Perceived Effectiveness and Self-efficacy. Items are rated on a 5-point Likert scale (e.g., 1 = strongly dislike, 5 = strongly like) and a mean is computed across all seven constructs (n=7 items) and a single outcome is examined for the general item. Total mean score ranges from 1 to 5, with higher scores indicating greater acceptability of the intervention.
- Objective 2: Satisfaction of HOPE-CAt 2-week post-intervention
Will be assessed by using three items assessing overall satisfaction. A cutoff score of ≥ 7 (out of 10) will be used for each satisfaction item.
- Objective 3: Optimization of the interventionAt 2-week post-intervention
Feedback will be gathered from clinicians who participated in the intervention to assess their feedback on how to optimize the intervention in clinical settings.
- Objective 3: Delivery of the interventionAt 2-week post-intervention
Feedback will be gathered from clinicians who participated in the intervention to assess their feedback on the delivery of the intervention in clinical settings.